Terminology shifts to “decompensated heart failure,” introducing an initial–stabilization–pre/postdischarge framework and ...

"Mortality Risk Rises 3.5-Fold if the Left Atrium Fails to Recover After Heart Failure Treatment" ...

An experimental drug has been shown to improve symptoms, exercise capacity and heart failure status in patients with an ...

Researchers found that urolithin A improved relaxation in engineered human heart tissue and reduced several hallmarks of ...

Pulmonary hypertension that is caused by left heart disease and is associated with heart failure may be driven by sympathetic overactivation leading to increased pulmonary vascular resistance, ...

New research shows that even dim light during sleep — as low as 3 lux — may thicken heart muscle walls and reduce heart ...

A novel oral relaxin receptor agonist was well tolerated and had favorable effects on hemodynamics in patients with heart ...

The ACCESS model is designed help more patients get treated and managed with advanced technologies. In addition to heart ...

Though neither a physiologist nor a physician, William Shakespeare, a master observer, deftly noted the central roles of the ...

Diastolic heart failure means there’s a problem with your heart’s ability to fill with blood. It’s a type of congestive heart failure where your heart cannot work efficiently, leading to fluid ...

Urolithin A heart failure research points to a new pathway for improving heart relaxation in a hard-to-treat condition.

Heart failure and chronic kidney disease (CKD) can both arise from diabetes and high blood pressure. Moreover, having CKD can put extra pressure on the heart, and heart failure can weaken kidney ...